KalVista, Carbylan Therapeutics deal

Carbylan will merge with KalVista in a stock deal, with KalVista expected to

Read the full 135 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE